All Business articles – Page 18
-
BusinessPfizer to close two manufacturing plants in India
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
-
BusinessChinese plant closures disrupt supply chains
Environmental clampdown knocks out major suppliers of some ingredients
-
BusinessBristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
-
BusinessHow many papers do you read a week?
Everyone needs a strategy to keep up with the literature
-
BusinessGSK and Pfizer joint venture creates new consumer healthcare giant
Enlarged GSK consumer health will have largest market share of any firm and be a leader in key countries
-
BusinessChemicals industry roundup 2018
Industry growth remains strong despite tariff disputes, political uncertainty and supply chain challenges
-
BusinessPharmaceuticals roundup 2018
Merger deals, product approvals and infrastructure changes have been overshadowed by political uncertainty, in Europe and around the world
-
BusinessBayer to cut 12000 jobs
As it integrates Monsanto businesses, Bayer will eliminate around 10% of its global workforce
-
BusinessSartan drug contamination brings cancer uncertainty
Levels of nitrosamines and other carcinogens in affected tablets of valsartan and related drugs similar to smoking 20 cigarettes a day
-
BusinessSensing the sweet spot
Ziylo’s selective glucose-binding molecule could open doors to smart insulin for diabetes
-
BusinessArrests in China follow massive leak into the Taiwan Strait
Seven charged with criminal negligence after release of 70 tonnes of aromatic hydrocarbons sickened over 50 people
-
BusinessBreaking the silence of RNA interference drugs
A wave of treatments is set to follow the first approval of an RNAi therapy
-
BusinessTransforming PET imaging with silicon
Fuzionaire Diagnostics can add Si–18F radiolabels to a variety of molecules quickly, easily and cheaply
-
BusinessLords criticise post-Brexit regulation plans
Current lack of preparedness risks ‘cliff-edge’ on exit day, committee warns
-
BusinessSmall biocides companies face uncertain fate
Cost and complexity of European law hampers innovation and excludes SMEs
-
BusinessCancer immunotherapy spreads rapidly
New approvals and expanded use for checkpoint inhibitor drugs illustrate the power of Nobel-winning science
-
BusinessCleaning up clinical trials
Campaigns to enforce complete and correct reporting of trial data are beginning to take hold
-
BusinessNovartis to cut over 2000 jobs
Move exemplifies a wave of manufacturing cuts as pharma moves to more high-value, specialised medicines
-
Business‘No deal’ Brexit guidance fails to reassure UK chemical industry
UK government issues guidance on chemical regulation and patent law if the UK leaves the EU without agreement
-
BusinessIndia moves to ban cocktail drugs
Government injunction on 328 fixed dose combinations is strongly opposed by manufacturers